Peptide record

TPDB44191

Antiviral standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44191
Antiviral
Anti-infective peptides
AI4AVP Peptipedia
standard
No
A 13-aa standard-residue antiviral peptide sequence curated from AI4AVP and Peptipedia, with an available 3D structural model.
Sequence
KGLSGPQGSWWVV
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C66H97N17O17
ARNDCEHIMFTY
G
1400.60
10.10
1
0
5
+1
-0.20
-0.108
74.62
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
11000
7.85
3
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
1
Q
3
G
0
H
0
I
1
L
1
K
0
M
0
F
1
P
2
S
0
T
2
W
0
Y
2
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 3 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 1 S: 2 T: 0 W: 2 Y: 0 V: 2
Chemical Descriptors
13 reviewed residue count
C66H97N17O17 sequence-only estimate (linear, free termini)
1400.60 sequence-only estimate (linear, free termini)
10.10 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-0.20 sequence-only estimate (linear, free termini)
-0.108 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA